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ABSTRACT: Biofunctionalized gold nanoparticles
(AuNPs) enable innovative translational research and
development in biomedicine. Biomolecules such as pep-
tides, proteins, lipids, and carbohydrates can be assembled
onto AuNPs to yield nanomaterials with unique properties
for applications in imaging, photothermal therapy, vacci-
nation strategies, and drug delivery. The characterization of
functionalized AuNPs still remains an analytical challenge
that normally requires the combination of multiple
techniques. Laser desorption/ionization (LDI) and matrix-
assisted LDI (MALDI) have been applied successfully in combination with time-of-flight (TOF) mass spectrometry (MS)
for the analysis of the surface chemistry of AuNPs functionalized with synthetic ligands, however only for ligands with a
molecular mass limited to 1000 Da. TOF-MS-based approaches in addition exhibit limited performance in terms of mass
resolution and MS/MS possibilities. To overcome these limitations, we designed an approach for the analysis of AuNPs
based on ultrahigh resolution Fourier transform ion cyclotron resonance (FTICR) MS and a combination of LDI and
MALDI. To illustrate the performance of the method, we present a comprehensive characterization of the surface
chemistry of AuNPs conjugated via a thiol-ending linker to either the ovalbumin peptide (OVA 323-339), the Lewis X
antigen (Galβ1-4[Fucα1-3]GlcNAcβ1) trisaccharide, the tetramannoside Manα1-2Manα1-2Manα1-3Manα1, or a mixture
of both carbohydrates. Collision-induced dissociation (CID) was used to characterize the structure of pseudomolecular
ions generated by LDI/MALDI in-depth. These included [M + H]+ and [M + Na]+, and importantly also [M + Au]+ and [M
+ 2Au−H]+ ions. This first observation of gold-containing pseudomolecular ions provides direct evidence for the Au-
conjugation of ligands. In addition, we show the applicability of the method to monitor proteolytic cleavage of peptides
that are conjugated to the AuNP surface. The presented LDI/MALDI−FTICR−MS and MS/MS approach will be
applicable to the characterization of a wide range of functionalized AuNPs.
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Gold nanoparticles (AuNPs) are versatile nanomaterialswith a vast field of applications.1,2 The possibility totailor specific biological, physical, and chemical
properties through particle size and via surface modification
makes AuNPs one of the most promising and studied tools in
nanotechnology-enabled biomedicine. AuNPs display a high
adsorption capacity due to a large surface-to-volume ratio, they
are relatively nontoxic, can be functionalized with a variety of
biomolecules, and they strongly interact with light by a physical
phenomenon called surface plasmon resonance. These
characteristics have stimulated the exploration of AuNPs in
medical applications including imaging, photothermal therapy,
vaccination, and drug delivery.3−6 Development of functional
nanoparticles that carry multiple (bio)molecules will further
extend the field of (biomedical) applications.2
AuNPs in the 2−100 nm size range are typically synthesized
in solution by redox reactions and can be functionalized by
introducing molecules containing a thiol group to form a strong
nanoparticle−sulfur bond.7,8 Structure characterization of the
surface of nanomaterials with regard to conjugation chemistry,
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ligand definition, and overall quality control is a key-factor in
the development of functionalized AuNPs. A suitable method
for the characterization of AuNPs must provide reliable
information on the composition of the AuNP surface with
respect to ligand structure, density, and stoichiometry.
Analytical techniques should also allow the detection of
possible modifications induced by the exposure to enzymes
and other reactants in a biological environment such as the
bloodstream or target organs. Clearly, characterization of
biofunctional AuNPs is challenging, and may require a
multimethod approach, including complementary analytical
techniques such as UV−vis, IR, and NMR spectroscopy,
enzyme-linked immunosorbent assay, X-ray crystallography,
and mass spectrometry (MS).9
MS has proved to be a powerful tool for the characterization
of functionalized AuNPs by providing information with regard
to the mass of the ligands.10 While ESI-MS and ESI-MS/MS
have been used for the characterization of gold nano-
clusters,11,12 laser desorption/ionization (LDI) MS has been
successfully applied in the mass analysis of various AuNPs
ligands;10,13−16 however, only small synthetic ligands (i.e.,
<1000 Da) could be analyzed.17 This limitation is caused by a
low desorption/ionization efficiency of specific ligands in
commercial matrix assisted LDI-time of flight (MALDI-TOF)
platforms and a decreased sensitivity of TOF mass analyzers at
higher m/z. The combination of LDI−MS with MALDI
allowed an enhancement of the detection of the ligands of
AuNPs in biological samples.18 LDI/MALDI methods rely on
the fact that AuNPs absorb laser irradiation resulting in the
release and ionization of ligands that are subsequently detected
by MS. For many applications, mass measurements by LDI/
MALDI−MS and tandem mass spectrometry (MS/MS) may
be required for full structural identification of complex ligands
such as lipids, peptides, and carbohydrates which are of interest
for biomedical applications and often have a mass higher than
1000 Da. Unfortunately, LDI/MALDI−MS analyses on AuNPs
have hitherto been performed on time-of-flight (TOF) MS
instruments with limited MS/MS possibilities.
To overcome the limitations of LDI-TOF−MS instruments
with respect to mass range, mass resolution, accuracy, and MS/
MS possibilities for the comprehensive analysis of biomolecular
functionalization of AuNPs, we here apply ultrahigh resolution
Fourier transform ion cyclotron resonance (FTICR) MS and a
combination of LDI and MALDI. FTICR MS provides the
highest resolving power, mass accuracy, and precision among
the different mass analyzers and provides a higher dynamic
range than TOF-MS.19,20 To illustrate the applicability of the
FTICR MS method, we characterize ∼2 nm AuNPs conjugated
via a thiol-ending linker to either the ovalbumin peptide (OVA
323-339), the Lewis X antigen (Galβ1-4[Fucα1-3]GlcNAcβ1)
trisaccharide, the tetramannoside Manα1-2Manα1-2Manα1-
3Manα1, or both carbohydrates. In addition, LDI/MALDI−
FTICR MS using 1,5-diaminonaphthalene (1,5-DAN) as a
matrix and collision-induced dissociation (CID) fragmentation
studies on pseudomolecular ions, such as [M + H]+, [M +
Au]+, and [M + 2Au−H]+, allowed unequivocal proof of
attachment and composition of ligands to the AuNP surface.
RESULTS AND DISCUSSION
OVA 323-339 peptide, Lewis X, and Tetramannoside
AuNPs. Peptide- and carbohydrate-functionalized AuNPs find
increased application in various biomedical research areas.21
For the current study, we synthesized AuNPs conjugated to the
immunogenic OVA 323-339 peptide, and two different
carbohydrate-coupled AuNPs. The OVA peptide was pre-
viously explored in the context of AuNPs as a T-cell epitope-
containing carrier for immunization with S. pneumonia
antigens.22 Carbohydrate AuNPs were constructed of a
tetramannoside, recently also used to mimic HIV gp120
oligomannose clusters,23,24 and of the immunomodulatory
Lewis X antigen.25 In each case a relatively long bifunctional
thiol-ending linker (i.e., SCN-TEG-C11-SH) was used to
couple the functional carbohydrate ligand through a thiourea
bond as previously described.26 A glucose thiol-ending short
derivative (i.e., -C5-SH) was used to modulate the density of
the functional carbohydrate ligands on the AuNPs while still
allowing them to protrude from the AuNP surface. A schematic
of the AuNPs used in this study is depicted in Figure 1.
Analysis of OVA 323-339 peptide AuNPs by LDI-, LDI/
MALDI−FTICR MS and MS/MS. In this study, we aimed to
analyze AuNPs functionalized with biomolecules with a mass
larger than 1000 Da. First, AuNPs of ∼2 nm conjugated to a
modified OVA 323-339 peptide (monoisotopic mass =
1917.912 Da) were analyzed by both LDI- and LDI/
MALDI−FTICR MS. As depicted in Figure 2A, LDI results
in a pseudomolecular ion of the OVA peptide ligand ([M +
Na]+), implying a release from the surface of the AuNPs upon
ionization. In combination with the 1,5-DAN matrix (Figure
2B) the spectrum changes dramatically: the OVA peptide
ligand is now observed as a protonated pseudomolecular ion at
m/z 1918.933 at a peak intensity about 80 times higher
compared to LDI. The 1,5-DAN MALDI matrix exhibits a high
hydrogen donor capacity which in general enhances the signal
compared to LDI-measurements (see Supporting Information,
Figure S1). LDI-TOF MS did not yield any ions of the OVA
peptide ligand, whereas LDI/MALDI-TOF MS resulted in a
low quality spectrum compared to LDI/MALDI−FTICR MS.
Thus, we conclude that the mass limitation of 1000 Da
reported earlier by Vachet and co-workers17 can be overcome
by LDI/MALDI-TOF MS, however for confident character-
izations LDI/MALDI−FTICR MS which offers superior mass
resolution and fragmentation capacity is required.
Interestingly, LDI/MALDI−FTICR MS allowed the detec-
tion of the OVA peptide ligand as [M + Au]+ and [M + 2Au−
H]+ at m/z 2114.892 and m/z 2310.859, respectively (Figure
Figure 1. Gold nanoparticles characterized in this study. AuNPs
were all functionalized with glucose-based ligands (indicated with
solid blue circles) and in addition with various ligands (one-pot
procedure described in Methods). Four different types of AuNPs
were obtained: (A) AuNP functionalized with an ovalbumin (OVA
323-339) peptide-based ligand; (B) AuNP functionalized with a
Lewis X ligand; (C) AuNP functionalized with a tetramannoside
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2B). To our knowledge, although Au+ ions have been detected
in LDI spectra of AuNPs,18,27 the generation of gold-cluster
ions linked to the ligands of functionalized AuNPs by LDI-MS
has never been reported. Upon using AuCl3 in combination
with alpha-cyano-4-hydroxycinnamic acid, gold ion-angiotensin
peptide complexes (i.e., [M + Au(I)]+ and [M + 2Au(I)−H]+)
have been observed in MALDI-spectra, with preferred
coordination sites for gold being Cys, His, and Arg as
determined from tandem-MS analysis.28 In our study, no single
Au+ ions or Au+ clusters were detected and both the synthesis
protocol (i.e., using 21 equiv of reducing agent) and the
purification procedures (i.e., extensive dialysis) rule out the
presence of free Au+ in solution. Thus, we rationalize that the
observed [M + Au]+ and [M + 2Au−H]+ species result from a
detachment of ligands together with Au+ ions from the
nanoparticle surface.
An advantage of LDI/MALDI−FTICR MS, essential to the
analysis of AuNPs with complex ligands, is the possibility of
combining accurate ion mass determination with tandem mass
spectrometry, using, for example, CID. The MS/MS spectra
with assignments of the [M + Au]+, and [M + H]+and [M +
2Au−H]+ species of the OVA peptide-based ligand are depicted
in Figure 2C and Figure S2, respectively. The CID of [M + H]+
resulted in fragments representing nearly all peptide bond
cleavages (sequence coverage 94%, Figure S2B), fully
confirming the OVA 323-339 amino acid sequence. In general,
for this species, b-type fragmentation was favorable compared
to y-type (a scheme of b- and y-type fragmentation is reported
in Figure S3), although the most abundant fragment ion was a
y-type ion detected at m/z 659.347 generated from the cleavage
between Glu11 and Ile12. Full sequence coverage was obtained
for [M + Au]+ (Figure 2D) and, as for [M + H]+, the most
abundant CID fragment was the protonated y-type ion detected
at m/z 659.347 (cleavage at Glu11-Ile12) suggesting that Au+ is
not localized on the C-terminal part of the peptide. The
detection of both protonated (more abundant) and gold-linked
(less abundant) fragment ions for the same fragmentation site
did not allow an unambiguous localization of Au+. However,
the data indicate that both the terminal sulfur and His9 are
preferred coordination sites of Au+. The MS/MS analysis of [M
+ 2Au−H]+ (Figure S2C,D) showed that the fragmentation
between Glu11 and Ile12 was not predominant and while y-
type ions carried one Au+ (main species), b-type ions carried
two gold atoms. This suggests that both His6 and the terminal
sulfur atom are involved in the coordination of Au+. Internal
fragmentation (see inset Supporting Information, Figure S2C)
resulted in low-intensity fragment ions containing His6 and
gold. These data obtained for [M + Au]+ and [M + 2Au−H]+
Figure 2. Relevant parts of the FTICR mass spectra of AuNPs with OVA 323-339 peptide-based ligand obtained from LDI only (A) and LDI/
MALDI (B). The use of 1,5-DAN as a MALDI matrix resulted in the detection of pseudomolecular ions [M + H]+, [M + Au]+, and [M + 2Au−
H]+, highlighted with three different colors. Additional pseudomolecular ions observed were (a) [M−S−H + 1,5-DAN]+ at m/z 2043.030, (b)
[M−H + 1,5-DAN]+ at m/z 2074.998, and (c) pseudomolecular ion of coupled glucose-based and OVA-based ligands at m/z 2199.038 (as
explained in the Results and Discussion section). Further structure characterization of [M + Au]+, [M + H]+, and [M + 2Au−H]+ was
performed by collision-induced dissociation (CID) and as an example the tandem mass spectrum of the first species is shown in C (the other
two can be found in Figure S2). The obtained high sequence coverages (D) allowed to determine the preferred coordination site(s) of Au+ by
evaluating all gold-containing fragment ions (indicated with yellow circles).
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species are indicative of the affinity of His6 and His9 for Au+ in
the gas phase only, since the structure of b- and y-type
fragments is an important factor for the coordination of cations.
In contrast, on the surface of AuNPs a gold−histidine bond is
energetically unfavorable compared to the strong gold−sulfur
bond. In fact, Aldeek et al. have shown that proteins expressing
an N-terminus polyhistidine tag self-assembled onto AuNPs
only when NPs were partially capped with thiol-terminated
ligands or were stabilized with a weakly binding cap such as
citrate groups.29
As previously reported, LDI of AuNPs functionalized
through an Au−S bond can lead to loss of SH2 from the
ligand resulting in the formation of a double bond between
adjacent carbons.13,18 As depicted in the inset in Figure 2B, this
loss was observed at m/z 1884.945. In addition, due to the high
hydrogen-donor capacity of the 1,5-DAN matrix, the reduced
form [M−S + H]+ of [M−SH2 + H]+ was detected at m/z
1886.960. The structural characterization of these species by
CID allowed confirmation of the presence/absence of a double
bond in the structure of the linker (Supporting Information,
Figure S4).
The OVA peptide AuNPs were synthesized using the glucose
ligand and the OVA peptide ligand at a concentration ratio of
about 9:1. The glucose ligand (theoretical m/z 282.1137) was
hardly detected by both LDI- and LDI/MALDI−FTICR MS.
Interestingly, the coupled glucose- and OVA peptide-ligand
attached to each other via an S−S bond was detected at m/z
2199.038 (Figure 2B). Earlier, Yan et al. reported the formation
of S−S bonds between ligands from monolayer-protected
AuNPs induced by LDI.13 The CID spectrum of the glucose-
OVA peptide species is reported in Figure S5. The most
abundant fragment ions were b-type ions generated after the
loss of the glucose molecule (i.e., fragment ion at m/z
2037.000), which is in line with the well-known lability of
glycosidic bonds in CID of protonated glycoconjugates.30 In-
source decay of the OVA peptide ligand was observed in both
LDI- and LDI/MALDI−FTICR MS analyses. Preliminary data
suggest that the use of sinapinic acid as the MALDI matrix
instead of 1,5-DAN can drastically reduce in-source decay
(Figure S6).
The detection of different forms of the OVA peptide ligand
shows the potential of our strategy for the analysis of ligands
with molecular weight higher than 1000 Da. In our previous
study, we have shown that MALDI−FTICR MS allows the
measurements at isotopic resolution of proteins up to about m/
z 17 000.31 From this, we rationalize that the analysis of
proteins linked to AuNPs is limited to similar sizes.
It is known from surface plasmon resonance studies that
AuNPs with different particle sizes have different light
absorption properties (e.g., from a laser). The here reported
strategies apply to AuNPs with a diameter of approximately 2
nm. An additional and independent evaluation would be
Figure 3. (A) Enzymatic digestion of the OVA 323-339 peptide-based ligand attached to a gold nanoparticle. (B) Resulting LDI/MALDI−
FTICR MS spectrum after Glu-C digestion. The most abundant product is derived from the cleavage at Glu11 and was detected as [M1 + H]
+
at m/z 1278.607, [M1 + Au]
+ at m/z 1474.571 and [M1 + 2Au−H]+ at m/z 1670.536. A second product is derived from the cleavage at Glu14
(with a missed cleavage at Glu11) and was detected as [M2 + H]
+ at m/z 1634.786. Other assignments are (a)[M1−S−H + 1,5-DAN]+ at m/z
1402.703. (b)[M−S−H + 1,5-DAN]+ at m/z 2043.052. (c)[M1−H + glucose ligand]+ at m/z 1558.715. (d)[M−H + glucose ligand]+ at m/z
2199.038. (C) Sequence coverage obtained from CID analysis of [M1 + Au]
+ (mass spectra of [M1 + H]
+, [M1 + Au]
+, and [M1 + 2Au−H]+ are
shown in Figure S7). The data suggests that the preferred coordination sites of Au+ are Histidine 6 and the terminal sulfur. Yellow circles =
[fragment + Au]+. Double yellow circles = [fragment + 2Au−H]+.
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needed in case larger particles were of interest, or other metal
or metal oxide were considered.
Enzymatic Digestion of OVA Peptide AuNPs and LDI/
MALDI−FTICR MS. In situ activation of AuNPs, for example
by the proteolytic cleavage of bioactive peptides or enzymatic
release of fluorescent molecules for visualization allows
innovative applications of AuNPs in biomedicine.32,33 There-
fore, it is essential to develop MS-methods for the character-
ization of biofunctionalized AuNPs after modification or
activation, providing information about the changes of surface
chemistry and composition. Here, we studied the surface
chemistry of the OVA peptide AuNPs after enzymatic
digestion. To this end, the OVA peptide AuNPs were partially
digested using endoproteinase Glu-C and then characterized by
LDI/MALDI−FTICR MS and MS/MS. The undigested intact
OVA peptide ligand was observed at m/z 1918.949 as major
species in the spectrum (Figure 3B). The OVA peptide
contains two theoretical cleavage sites at Glu11 and Glu14
(Figure 3A). The shorter OVA peptide ligand generated from
the cleavage at Glu11 ([M1 + H]
+ in Figure 3B) was detected at
m/z 1278.607 while the ligand generated from the cleavage at
Glu14 and missed cleavage at Glu11 ([M2 + H]
+ in Figure 3B)
was detected at m/z 1634.786 at lower peak intensity. As for
the intact OVA peptide ligand, also the shorter M1 peptide was
detected bound to one or two Au+, the glucose ligand and the
1,5 DAN matrix. The species generated from the loss of either
SH2 or S were also detected. The MS/MS spectra and sequence
coverage generated from the analysis of [M1 + H]
+, [M1 +
Au]+, and [M1 + 2Au−H]+ are reported in Supporting
Information Figure S7, and Figure 3. While b-type
fragmentation was preferred for [M1 + H]
+, y-type fragments
were more abundant for the gold-complexed species. The
characterization of [M1 + Au]
+ suggests that Au+ is coordinated
at His6 while the second Au+ of [M1 + 2Au−H]+ is localized on
the terminal sulfur of the linker. CID analysis also confirmed
the structure of the M1 ligand linked to the glucose ligand via
an S−S bond detected at m/z 1558.715 (Supporting
Information Figure S7).
Together these data confirm the successful proteolysis by
Glu-C of the OVA peptide at the surface of the AuNPs and
show the potential of this method for monitoring of in vitro or
in vivo ligand modifications. Our strategy allowed to detect
enzymatic modifications of the AuNPs on the particles
themselves in contrast to the detection of cleavage products,
released from the particles.
Analysis of Lewis X and Tetramannoside AuNPs by
LDI/MALDI−FTICR MS and MS/MS. AuNPs functionalized
with two different carbohydrate ligands were analyzed by LDI/
MALDI−FTICR MS, namely the Lewis X ligand (mono-
isotopic mass = 993.4749 Da) and the tetramannoside ligand
(monoisotopic mass = 1130.4961 Da). The LDI/MALDI−
FTICR spectrum of Lewis X AuNPs is reported in Figure 4.
Here, the most abundant species detected at m/z 982.484 was
identified as [M−SH2 + Na]+. MS/MS analysis (Supporting
Information, Figure S8) confirmed the loss of SH2 generated
from the terminal thiol group of the linker (Figure 4B).
Interestingly, a double loss of SH2 was observed at m/z
948.495. This double loss generated from both the terminal
thiol group and the thiourea group of the linker. These losses
were not observed in the MALDI−FTICR−MS analysis of the
purified Lewis X ligand (i.e., not linked to AuNPs; Supporting
Information, Figure S9) which indicates that the sulfur at the
thiourea group may also form a bond with gold. Contrary to
what was observed for the OVA peptide, the [M−S + Na]+ was
not detected. In-source decay of [M−SH2 + Na]+ led to the
loss of fucose from the carbohydrate moiety (i.e., species
detected at m/z 836.424).
Fragmentation of carbohydrates by CID provides detailed
structural information from glycosidic linkage cleavages as well
as cross-ring cleavages.34 The CID spectra from Lewis X and
tetramannoside ligands were evaluated based on the identi-
fication of glycosidic cleavages. The characterization of [M +
Na]+, [M + H]+ [M + Au]+ by CID resulted in different
fragmentation patterns (Supporting Information Figure S8 and
Figure 4) and provided complementary information on the
structure of the ligand. In fact, the larger ion generated from the
fragmentation of the Gal(β1-4)-GlcNAc bond was only
detected in the MS/MS spectrum of [M + Au]+ at m/z 882
and not in the MS/MS spectra of [M + H]+ and [M + Na]+.
Other examples of fragment ions providing complementary
information are those detected in the CID spectrum of [M +
H]+ at m/z 465 and 512 and those in the spectrum of [M +
Na]+ at m/z 595 and 637. The presence of gold-clustered
fragments indicated that Au+ was not localized on the
carbohydrate part but rather in the proximity of the terminal
sulfur of the linker. Further evidence for this localization was
provided by the detection of the gold-clustered fragment at m/z
576. The species detected at m/z 1000.494 was identified as a
Lewis X ligand with urea instead of a thiourea in the structure
of the linker.
The LDI/MALDI−FTICR MS analysis of the tetramanno-
side AuNPs led to the detection of ion species similar to those
Figure 4. (A) LDI/MALDI−FTICR MS spectrum of AuNP
functionalized with Lewis X-based ligand. The use of NaCl in the
spotting procedure led to the detection of the intact Lewis X ligand
at low intensity as [M + H]+, [M + Na]+, and [M + Au]+, and the
detection of fragmented species at higher intensity such as [M−SH2
+ Na]+ and [M−SH2−Fuc + Na]+. (B) From structural character-
ization performed by CID a double bond resulting from the loss of
SH2 was confirmed. Furthermore, MS/MS data of three different
pseudomolecular ions provided structure confirmation of the Lewis
X-based ligand. The analysis of the [M + Au]+ suggests the terminal
sulfur as the preferred coordination site of Au+. Yellow circles
indicate gold-linked fragment ions.
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detected for the Lewis X AuNPs (see Figures 4 and 5). Also in
this case, the most abundant peak in the spectrum was
identified as [M−SH2 + Na]+. The fragmentation patterns of
[M + Na]+ and [M + Au]+ were clearly different with [M +
Na]+ providing more information on the structure of the linker
(i.e., fragments at m/z 444, 774, and 732) while [M + Au]+
provided more information on the structure on the
carbohydrate part (i.e., fragments at m/z 841, 1003, 1165)
(Figure 5B). The detection of gold-clustered fragments
indicates that the Au+ is localized on the terminal sulfur of
the linker (Supporting Information Figure S10 and Figure 5B).
As for the Lewis X AuNPs, the detection of the fragment at m/z
576 in the MS/MS spectrum of [M + Au]+ provided additional
evidence for this localization. Interestingly, when NaCl was not
used in combination with the 1,5-DAN matrix, the tetramanno-
side ligand was detected at high intensity as [M + H]+, [M +
Au]+, and [M + 2Au−H]+ (Supporting Information Figure
S11).
To explore the applicability of LDI/MALDI−FTICR MS for
the analysis of AuNPs with mixed functional ligands, we
analyzed AuNPs carrying both Lewis X and tetramannoside.
The ligand ratio anticipated on the basis of reaction
stoichiometry and measured by 1H NMR spectroscopy was
approximately 1:2, and the ratio between these ligands as
detected by LDI/MALDI−FTICR MS and determined as
([M1−SH2 + Na]+ + [M1−S + O + Na]+ + [M1 + Na]+)/
([M2−SH2 + Na]+ + [M2-S + O + Na]+ + [M2 + Na]+) was
∼3.0 (see Figure 6 and Figures S13−S15). Although it is clear
that these results may be biased due to different ionization
efficiencies for the different ligand species, it shows the
potential of this approach to determine ligand ratios after
synthesis of multicomponent AuNPs or for example after
dynamic covalent exchange, as previously reported using LDI-
MS-based methods.13,14
CONCLUSIONS
We performed detailed structural characterization of peptide
and carbohydrate functionalized AuNPs of ∼2 nm using a
combination of LDI/MALDI−FTICR MS and CID. The here
described strategy allows the structural analysis of AuNPs with
ligands larger than 1000 Da by generating spectra of a much
higher quality than spectra obtained with previously described
LDI-TOF MS methods, including fragmentation spectra. All
analyzed AuNPs were functionalized with either the OVA 323-
339 peptide, the Lewis X antigen, or the tetramannoside, or a
combination of the latter two ligands. The MS analysis of these
AuNPs allowed for the detection of the ligands as
pseudomolecular species, such as [M + H]+, [M + Na]+, [M
+ Au]+, and [M + 2Au−H]+ and the detection of modified
ligands, such as [M−SH2 + Na]+, which were formed during
ionization. We showed that LDI/MALDI-CID-FTICR MS
allows for the in-depth structural characterization of these
species providing comprehensive information on the surface
chemistry of biofunctionalized AuNPs. In fact, MS/MS analysis
allowed identification of the ligands present on the surface of
AuNPs and an understanding of how these ligands can be
linked to or interact with gold atoms. The identification and
characterization of different [M + nAu]+ species could be used,
in general, to confirm AuNP surface attachment of thiol
coupled ligands. To our knowledge, the generation of these
gold-containing ions directly from AuNPs has never been
reported.
In addition, using the endoproteinase Glu-C, we showed that
the OVA peptide AuNPs can be enzymatically modified and
that surface modifications can be monitored by LDI/MALDI−
FTICR MS, further indicating the potential of the approach in
the field of AuNP research and development.
Figure 5. (A) LDI/MALDI−FTICR MS spectrum of AuNP
functionalized with tetramannoside-based ligand. The tetramanno-
side-based ligand was detected as [M + H]+, and [M + Au]+ at low
intensity, and detected as [M + Na]+, [M−SH2 + Na]+ and [M−S +
O + Na]+ at higher intensities. (B) Structure characterization
performed by CID confirmed the identity of these species.
Fragmentation of [M + Au]+ allowed characterization of the
carbohydrate moiety of the ligand, whereas CID analysis of [M +
Na]+ provided more information on the structure of the linker.
Yellow circles indicate gold-linked fragment ions.
Figure 6. (A) 1H NMR spectrum of AuNPs functionalized with
both Lewis X and tetramannoside ligands in D2O at 500 MHz. A
detailed description of the NMR spectrum is reported in
Supporting Information Figure S13. (B) LDI/MALDI−FTICR
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METHODS
Conjugation of AuNPs with OVA Peptide, Lewis X Antigen
and Tetramannoside. Four different types of AuNPs functionalized
with thiol-ending derivatives of OVA 323-339 peptide, Lewis X, and
tetramannoside were prepared as previously described (Figure 1).22,26
For each AuNP a thiol-ending derivative of glucose (i.e., 5-
(mercapto)pentyl β-D-glucopyranoside) was used as the inner
component to allow the incorporation of defined proportions of
ligands, controlling their loading on the AuNPs (i.e., 10% of total
surface load). To this end, a 9:1 mixture of inner component-ligand
was used for the synthesis. Thus, AuNPs were functionalized with a
thiol-ending conjugate of either a tetramannoside (Manα1-2Manα1-
2Manα1-3Manα) or a Galβ1-4[Fucα1-3]GlcNAcβ1 (Lewis X antigen)
or a 1:2 mixture of the two carbohydrates (i.e., ligands), as previously
described.22,26,35 The OVA 323-339 peptide with an additional glycine
and mercapto-propionic acid linker at the N-terminus HS(CH2)2C-
(O)GISQAVHAAHAEINEAGR was obtained from GenScript Corp
(Piscataway, NJ, USA,); AuNPs carrying 10% of OVA 323-339 peptide
and 90% of inner component were prepared as previously described.22
Briefly, a water solution of tetrachloroauric acid (HAuCl4, Strem
Chemicals, 0.025 M, 1 equiv) was added to a 0.012 M (3 equiv)
MeOH solution of the mixture of 10% thiol-ending conjugates and
90% of glucose-conjugate. A solution of NaBH4 1 M (21 equiv) was
then added, and the black suspension was shaken for 2 h at room
temperature. Thus, obtained AuNPs were washed with EtOH and
MeOH, dissolved in a minimal volume of nanopure water and purified
by dialysis (3500 Da MWCO), 5 times with 5 L during 72 h.
Transmission electron microscopy showed a mean gold core diameter
of approximately 2 nm for all the prepared AuNPs. Detailed
experimental conditions for the synthesis of each NP and supporting
structural information are reported in Supporting Information pages
S13−S15. For the analysis of the ligand ratio on the AuNPs, proton
nuclear magnetic resonance (1H NMR) was used as previously
described.22,36 Before MALDI−FTICR−MS analysis AuNPs were
washed with nanopure water (3 times with 500 μL) on 30 kDa
centrifugal filters and AuNPs were suspended in nanopure water to a
final concentration of 1−2 mg/mL.
Enzymatic Digestion of OVA Peptide AuNPs. Endoproteinase
Glu-C with enzymatic activity ≥ 15 units/mg protein was purchased
from Sigma-Aldrich. This solution was diluted 1 to 1000 in water, and
1 μL was mixed with 10 μL of 1 mg/mL solution of OVA 323-339
AuNPs. This mixture was then incubated for 4 h at 37 °C. Digested
OVA 323-339 AuNPs were analyzed by MS without any further
purification.
LDI and MALDI Spotting. For LDI analysis, each solution of
functionalized AuNPs was spotted (1 μL) onto a ground-steel
MALDI-target plate either undiluted or after a 1:10 dilution with
solution A (50% ACN, 49.95% water, and 0.05% formic acid). For
LDI/MALDI analysis, 1 μL of the same solutions was spotted onto a
ground-steel MALDI-target together with a saturated solution of either
1,5 diaminonaphthalene (1,5-DAN) or sinapinic acid (SA), both
prepared in solution A. One microliter of a NaCl solution at 1 mg/mL
was mixed on the MALDI-target plate with each AuNPs solution and
MALDI matrixes.
LDI- and LDI/MALDI−FTICR MS and MS/MS. All LDI- and
LDI/MALDI-ESI-FTICR MS experiments were performed on a 15T
solariX XR FTICR mass spectrometer controlled by ftmsControl
software and equipped with a CombiSource and a ParaCell (Bruker
Daltonics, Bremen, Germany). A Bruker Smartbeam-II Laser System
was used for irradiation at a frequency of 500 Hz using the “medium”
predefined shot pattern. The instrumental parameters were tuned for
optimal sensitivity in the m/z-ranges between 92 and 5000 and 966.1−
5000. The number of laser shots, laser power, and number of acquired
scans were optimized for each type of functionalized AuNP. MALDI−
FTICR spectra were generated with 1 M data points. Precursor ions
were isolated through a quadrupole (Q), accumulated in the hexapole
collision cell, and fragmented by collision-induced dissociation (CID).
Accumulation times and collision energies were optimized for each
precursor ion. DataAnalysis Software 4.2 (Bruker Daltonics) was used




The Supporting Information is available free of charge on the
ACS Publications website at DOI: 10.1021/acsnano.7b03402.
Further MS and MS/MS spectra and peptide sequence
coverage from biofunctionalized AuNPs analyzed in this
study; detailed experimental conditions for the synthesis
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